These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2378778)

  • 1. Effect of major surgery on absorption rate of NPH insulin injected s.c.
    Hjortrup A; Madsbad S; Andersen M; Sørensen C
    Br J Anaesth; 1990 Jun; 64(6):741-2. PubMed ID: 2378778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.
    Owens DR; Coates PA; Luzio SD; Tinbergen JP; Kurzhals R
    Diabetes Care; 2000 Jun; 23(6):813-9. PubMed ID: 10841002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs.
    Jørgensen KH; Hansen AK; Buschard K
    Diabetes Res Clin Pract; 2000 Dec; 50(3):161-7. PubMed ID: 11106830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of isophane (NPH) insulin and its clinical implications.
    Lauritzen T; Pramming S; Gale EA; Deckert T; Binder C
    Br Med J (Clin Res Ed); 1982 Jul; 285(6336):159-62. PubMed ID: 6807390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site.
    Henriksen JE; Vaag A; Hansen IR; Lauritzen M; Djurhuus MS; Beck-Nielsen H
    Diabet Med; 1991 Jun; 8(5):453-7. PubMed ID: 1830531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.
    Hildebrandt P; Birch K; Sestoft L; Vølund A
    Acta Med Scand; 1984; 215(1):69-73. PubMed ID: 6364700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between subcutaneous blood flow and absorption of lente type insulin.
    Hildebrant P; Mehlsen J; Birch K; Kühl C
    Diabetes Res; 1987 Apr; 4(4):179-81. PubMed ID: 3621801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulin.
    Thow JC; Johnson AB; Marsden S; Taylor R; Home PD
    Diabet Med; 1990 Nov; 7(9):795-9. PubMed ID: 2148131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise augments the absorption of isophane (NPH) insulin.
    Thow JC; Johnson AB; Antsiferov M; Home PD
    Diabet Med; 1989; 6(4):342-5. PubMed ID: 2524341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique.
    Thow JC; Johnson AB; Fulcher G; Home PD
    Diabet Med; 1990 Aug; 7(7):600-2. PubMed ID: 2146067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotelemetric detection of the disappearance of subcutaneously injected 125I-NPH insulin.
    Kølendorf K; Bojsen J
    Clin Physiol; 1982 Feb; 2(1):13-20. PubMed ID: 7049511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption kinetics of regular and isophane (NPH) insulin in the normal dog.
    Goeders LA; Esposito LA; Peterson ME
    Domest Anim Endocrinol; 1987 Jan; 4(1):43-50. PubMed ID: 3333933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthostatic changes in subcutaneous blood flow and insulin absorption.
    Hildebrandt P; Birch K; Sestoft L; Nielsen SL
    Diabetes Res; 1985 Jul; 2(4):187-90. PubMed ID: 3910326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
    Luzio SD; Beck P; Owens DR
    Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption kinetics of short- and intermediate-acting insulins after jet injection with Medi-Jector II.
    Houtzagers CM; Berntzen PA; van der Stap H; Heine RJ; van der Veen EA
    Diabetes Care; 1988 Oct; 11(9):739-42. PubMed ID: 3066607
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.
    Lucidi P; Porcellati F; Marinelli Andreoli A; Carriero I; Candeloro P; Cioli P; Bolli GB; Fanelli CG
    Diabetes Care; 2015 Dec; 38(12):2204-10. PubMed ID: 26358287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective absorption of injected insulin.
    Lancet; 1978 Sep; 2(8092 Pt 1):741. PubMed ID: 80671
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of subcutaneous NPH insulin in diabetics.
    Kølendorf K; Bojsen J
    Clin Pharmacol Ther; 1982 Apr; 31(4):494-500. PubMed ID: 7060331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucodynamics and pharmacokinetics of 70/30 vs. 50/50 NPH/regular insulin mixtures after subcutaneous injection.
    Krug EI; DeRiso L; Tedesco MB; Rao H; Korytkowski MT
    Diabetes Care; 2001 Sep; 24(9):1694-5. PubMed ID: 11522727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.